Liaoning Chengda Biotechnology Co. Ltd. A (688739 SHG) stock market data APIs
Liaoning Chengda Biotechnology Co. Ltd. A Financial Data Overview
Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use worldwide. It offers inactivated Japanese encephalitis vaccine (IJEV) and SPEEDA-rabies vaccine. The company's rabies and influenza vaccines are in the new drug application stage; haemophilus influenzae type b vaccine in phase III; recombinant human papillomavirus 15-valent vaccine is in phase II; and 13-valent pneumococcal polysaccharide conjugate and varicella, as well as the live meningococcal A, C, Y and W-135 conjugate vaccine are in phase I. Its Serogroup B meningococcal outer membrane vesicle, 20-valent pneumococcal polysaccharide conjugate, recombinant zoster vaccine, multivalent HFMD (hand foot and mouth disease), high-dose influenza, and inactivated rabies monoclonal antibody vaccine are in the pre-clinical stage. Liaoning Chengda Biotechnology Co.,Ltd. was founded in 2002 and is headquartered in Shenyang, China. Liaoning Chengda Biotechnology Co.,Ltd. is a subsidiary of Liaoning Cheng Da Co., Ltd.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Liaoning Chengda Biotechnology Co. Ltd. A data using free add-ons & libraries
Get Liaoning Chengda Biotechnology Co. Ltd. A Fundamental Data
Liaoning Chengda Biotechnology Co. Ltd. A Fundamental data includes:
- Net Revenue: 1 469 M
- EBITDA: 388 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Liaoning Chengda Biotechnology Co. Ltd. A Earnings data
What’s included:
- Latest Release: 2023-03-31
- EPS/Forecast: NaN
Get Liaoning Chengda Biotechnology Co. Ltd. A End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
